These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 9127623

  • 21. [Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist].
    Habu Y, Oyasu K, Wakamatsu T, Sumitomo Y, Kiyota K, Inokuchi H, Kawai K.
    Nihon Rinsho; 2000 Sep; 58(9):1881-5. PubMed ID: 11004820
    [Abstract] [Full Text] [Related]

  • 22. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
    Katz PO.
    Rev Gastroenterol Disord; 2006 Sep; 6(3):136-45. PubMed ID: 16957654
    [Abstract] [Full Text] [Related]

  • 23. [Current concepts in therapy of reflux disease].
    Kirchgatterer A, Aschl G, Hinterreiter M, Stadler B, Knoflach P.
    Wien Med Wochenschr; 2001 Sep; 151(11-12):266-9. PubMed ID: 11515224
    [Abstract] [Full Text] [Related]

  • 24. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
    Katz PO, Tutuian R.
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):371-84. PubMed ID: 11403533
    [Abstract] [Full Text] [Related]

  • 25. Proton pump inhibitors: cost-effective agents for management of reflux-induced esophagitis.
    Gregor JC.
    Am J Manag Care; 2000 Aug; 6(8):934-5. PubMed ID: 11186505
    [No Abstract] [Full Text] [Related]

  • 26. Medical treatment of gastroesophageal reflux disease: options and priorities.
    Thomson AB.
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():14-23. PubMed ID: 1349550
    [Abstract] [Full Text] [Related]

  • 27. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease.
    Garnett WR.
    Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S11-8. PubMed ID: 8097363
    [Abstract] [Full Text] [Related]

  • 28. Management of gastroesophageal reflux disease.
    Heidelbaugh JJ, Nostrant TT, Kim C, Van Harrison R.
    Am Fam Physician; 2003 Oct 01; 68(7):1311-8. PubMed ID: 14567485
    [Abstract] [Full Text] [Related]

  • 29. Medical therapy of gastroesophageal reflux disease in secondary and tertiary care settings.
    Tytgat GN.
    Yale J Biol Med; 1999 Oct 01; 72(2-3):219-26. PubMed ID: 10780584
    [Abstract] [Full Text] [Related]

  • 30. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD, Croffie JM, Gupta SK, Molleston JP, Eckert GJ, Corkins MR, Fitzgerald JF.
    J Pediatr Gastroenterol Nutr; 2006 Feb 01; 42(2):160-5. PubMed ID: 16456408
    [Abstract] [Full Text] [Related]

  • 31. Treatment of gastroesophageal reflux: the role of proton pump inhibitors.
    Schulman MI, Orlando RC.
    Adv Intern Med; 1995 Feb 01; 40():273-302. PubMed ID: 7747649
    [No Abstract] [Full Text] [Related]

  • 32. Medical therapy of extraesophageal gastroesophageal reflux disease.
    Katz PO.
    J Clin Gastroenterol; 2000 Apr 01; 30(3 Suppl):S42-4. PubMed ID: 10777172
    [Abstract] [Full Text] [Related]

  • 33. Treatment of oesophageal bile reflux in children: the results of a prospective study with omeprazole.
    Orel R, Brecelj J, Homan M, Heuschkel R.
    J Pediatr Gastroenterol Nutr; 2006 Apr 01; 42(4):376-83. PubMed ID: 16641575
    [Abstract] [Full Text] [Related]

  • 34. Management strategies for gastroesophageal reflux disease.
    Bak YT.
    J Gastroenterol Hepatol; 2004 Sep 01; 19 Suppl 3():S49-53. PubMed ID: 15324382
    [Abstract] [Full Text] [Related]

  • 35. Therapy for gastroesophageal reflux disease: more is not necessarily better.
    Metz DC.
    Am J Gastroenterol; 2003 Sep 01; 98(9):1913-5. PubMed ID: 14499765
    [No Abstract] [Full Text] [Related]

  • 36. [Conservative treatment of florid peptic esophageal stenosis. Complete elimination by dilatation and omeprazole in H2-blocker refractory cases].
    Koop H, Katschinski M, Arnold R.
    Med Klin (Munich); 1991 Nov 15; 86(11):566-8. PubMed ID: 1685214
    [Abstract] [Full Text] [Related]

  • 37. [Therapeutic procedures in gastroesophageal reflux disease].
    Tytgat GN.
    Z Gastroenterol; 1986 Sep 15; 24 Suppl 2():40-4. PubMed ID: 2877526
    [Abstract] [Full Text] [Related]

  • 38. Clinical studies of sucralfate in reflux esophagitis. The European experience.
    Hameeteman W.
    J Clin Gastroenterol; 1991 Sep 15; 13 Suppl 2():S16-20. PubMed ID: 1885899
    [Abstract] [Full Text] [Related]

  • 39. Cost effectiveness of rabeprazole versus generic ranitidine for symptom resolution in patients with erosive esophagitis.
    Ofman JJ, Yamashita BD, Siddique RM, Larson LR, Willian MK.
    Am J Manag Care; 2000 Aug 15; 6(8):905-16. PubMed ID: 11186502
    [Abstract] [Full Text] [Related]

  • 40. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials.
    Koelz HR.
    Scand J Gastroenterol Suppl; 1989 Aug 15; 156():25-36. PubMed ID: 2568015
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.